Park Ha Biological director files initial Form 3

Park Ha Biological Technology Co., Ltd. director Yu Xiaozhong filed an initial Form 3 to report insider status with respect to BYAH.

Accepted by SEC EDGAR 04/07/2026 - 08:26 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Park Ha Biological Technology Co., Ltd. director Yu Xiaozhong filed an initial Form 3 to report insider status with respect to BYAH. The filing lists Yu as a director and confirms that, at the time of this report, no insider transactions or derivative positions are reported.

Key Terms

Form 3, reporting person, ten percent owner

3 terms

Form 3 regulatory

"filed an initial Form 3 to report insider status"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

"The reporting person is identified as a director"

ten percent owner regulatory

"is_ten_percent_owner: 0"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the BYAH Form 3 filed by Yu Xiaozhong report?

The Form 3 for BYAH reports that Yu Xiaozhong is a director of Park Ha Biological Technology Co., Ltd. It is an initial insider ownership statement and shows no reported transactions or derivative positions at the time of filing.

Does the BYAH Form 3 show any insider buying or selling activity?

No. The BYAH Form 3 lists no insider transactions for Yu Xiaozhong. The transaction summary shows zero buy, sell, acquire, dispose, exercise, gift, or tax-withholding entries, indicating only a status report rather than trading activity.

Is Yu Xiaozhong identified as a ten percent owner in BYAH on this Form 3?

No. The Form 3 indicates that Yu Xiaozhong is a director of Park Ha Biological Technology Co., Ltd. and is not classified as a ten percent owner. The ten percent owner field for the reporting person is marked as not applicable.

What derivative positions are disclosed for BYAH in this Form 3?

The BYAH Form 3 shows no derivative positions for Yu Xiaozhong. The derivative summary is empty and the transaction summary lists zero derivative transactions, so there are no options, warrants, or other derivatives reported in this initial statement.

What is the purpose of this BYAH Form 3 for investors?

This Form 3 formally identifies Yu Xiaozhong as an insider and director of BYAH’s issuer, Park Ha Biological Technology Co., Ltd. It establishes regulatory disclosure of insider status but does not show any share purchases, sales, or derivative holdings at this time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Yu Xiaozhong

(Last) (First) (Middle)

3F, NO. 397, ZHONGNAN WEST ROAD

BINHU DISTRICT

(Street)

WUXI 214000

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/30/2024

3. Issuer Name and Ticker or Trading Symbol
Park Ha Biological Technology Co., Ltd. [ BYAH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Yu Xiaozhong	04/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)